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Abstract
Background: C-reactive protein (CRP) is an indicator of inflammation, and is often used in the
diagnosis of bacterial infections. It is poorly known whether CRP in bacterial infection is age-
dependent.
Methods: Adult patients with a positive blood culture with E. coli or S. pneumoniae during 1994–
2004 were included. CRP measured on the same date as the blood cultures were drawn (CRP1),
2–3 days (CRP2) and 4–7 days later (CRP3), were retrieved. The patients were divided into three
age groups, < 65, 65–84, and ≥ 85, respectively. We studied three cut-off values for CRP and
produced age-specific receiver operating characteristics (ROC) curves, using patients with acute
coronary or cerebral infarction as controls.
Results: 890 patients and 421 controls were available. There was a statistically significant negative
correlation between age and CRP1 – 0.072 (p = 0.032). The median CRP1 and CRP2 were
significantly higher in the youngest age group. The area under the ROC-curve for the youngest age
group was significantly greater than that of the two other age groups, but we found no statistically
significant differences in sensitivity related to age. The diagnostic sensitivity of CRP was better for
S. pneumoniae than for E. coli, 92.6% vs. 88.0% (p = 0.046) for a cut-off value of 40 mg/L, and 82.4%
vs. 61.5% (p =< 0.01) for a cut-off value of 120 mg/L.
Conclusion: CRP is better in identifying infection with S. pneumoniae than with E. coli. We found
a weakening of the CRP-response with age, but this is hardly of clinical significance.
Background
C-reactive protein (CRP) is the prototypical acute phase
protein in humans [1,2]. It is widely used as a marker of
infection, and also to aid the differentiation between a
bacterial and a viral origin. Many geriatricians have the
clinical impression that the CRP response to serious inva-
sive bacterial infections may be delayed in frail old
patients. This view is not supported in the literature [1],
but studies in this field are rather scanty. Some relatively
small studies exist [3-5], but were not designed to com-
pare the diagnostic sensitivity for bacterial infections in
different ages, and do not give information on the propor-
tion of false-negative tests.
CRP is mainly produced by the liver [6]. The synthetic
function of the liver may be reduced due to physiological
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aging, possibly due to both decreases in liver volume, liver
blood flow and perfusion, and to cellular changes [7]. The
main stimulator of CRP synthesis in the liver is interleukin
6 (IL-6), which is associated with diseases of old age such
as multiple myelomas, chronic lymphatic leukaemia and
renal cancer [8], and is higher in older than in younger
subjects [9]. In mice the regulation of IL-6 synthesis is
dependent of dehydroepiandrosterone, a hormone that
declines with age, and the dysregulation is reversed by
replacement of the hormone [10]. Studies have found a
delayed IL-6 response in infection in the old [11], as well
as impaired production of proinflammatory cytokines
[12]. Thus, a diminished or delayed CRP response to bac-
terial infections in the old may be biologically plausible.
The issue is clinically important, as the atypical clinical
symptoms and signs of infection in geriatric patients make
a correct diagnosis more dependent on a rational use of
supplementary tests.
Hogarth et al suggest a cut-off value of CRP at 40 mg/L to
be sufficient in elderly patients with infection [13],
whereas one study has recommended that the cut-off
value indicating sepsis, irrespective of age, should be 80
mg/L [14]. Even higher cut-off levels are also commonly
used in clinical decisions.
E. coli is the most frequent Gram-negative species in
bloodstream infections [15], whereas S. pneumoniae is the
leading cause of community-acquired pneumonia and a
significant cause of bacteraemia and meningitis [16].
Bacteraemia with either of these species will in almost
every instance represent a clinically important invasive
infection in need of antibacterial treatment. A "normal"
CRP-concentration in these conditions can therefore be
considered a false negative test result if CRP should be
regarded as an indicator of bacterial infection.
The main aim of this study was to assess the diagnostic
sensitivity of a raised CRP-concentration for bacteraemia
with either E. coli or S. pneumoniae in different age groups.
We also studied the impact of different cut-off points for
the CRP-concentration as well as differences in the time
course of the CRP-response in relation to age.
Methods
Setting and selection of patients
Aker University Hospital is a 350-bed hospital in Oslo,
Norway, serving a population of 500 000 for urology and
abdominal vascular surgery, and 180 000 for internal
medicine, general surgery and psychiatry. Until the late
1990's, the hospital served the latter population in gynae-
cology, obstetrics and paediatrics as well.
All adult (≥ 16 years) patients with culture-verified bacter-
aemia of E. coli or S. pneumoniae during the period 1994–
2004 were retrieved from the database of the hospital's
bacteriological laboratory. Patients having more than one
episode of bacteraemia were registered only once. For ana-
lytical purposes, the patients were divided into three age
groups, < 65, 65–84, and ≥ 85, respectively. To be able to
evaluate the need for age differentiated cut points for CRP,
we selected patients admitted to the Medical department
with ICD 10 diagnoses corresponding to either acute
myocardial or acute cerebral infarction during 2003 to
serve as controls. Patients with any ICD10 diagnoses indi-
cating severe infection or a positive blood culture with a
significant bacterium were, however, not used as controls.
Microbiological methods
Blood was cultured by the Bactec 9240 system (Becton &
Dickinson, Sparks, MD, USA). Further identification of
the positive blood cultures followed standard procedures
of the laboratory. Growth of possible S. pneumoniae was
confirmed by a typical phenotype, sensitivity to optochin
and by an agglutination test (Slidex pneumo-Kit, BioMéri-
ux, Lyon, France). E. coli was identified by a three tube
method for identification of Gram-negative rods [17], or
by the api20E system (BioMériux).
CRP analysis
From the databases of the clinical chemistry laboratory,
we retrieved the CRP concentration in blood drawn on the
same date as the blood culture, if applicable (CRP1).
When available, we also retrieved one CRP value meas-
ured on the second or third day of the hospital stay
(CRP2), and one retrieved between day four and day
seven (CRP3). All the CRP-measurements were performed
on automated clinical chemistry analyzers (Roche Diag-
nostics, Mannheim, Germany): first on Hitachi 717, then
Hitachi 917 and then on Modular. The assay vendor in the
actual period was Roche diagnostics. The assay is based on
an immunoturbidometric principle, where CRP is aggluti-
nated with anti-CRP. In 2004 the assay was changed to a
latex-particle-bound-anti-CRP reagent, which gave an
enhanced agglutination signal with CRP. No significant
shift in results could be detected at the time of change,
comparing the old and new methods in selected clinical
specimens. The analytic stability over the time period was
documented by stable values of daily long-time quality
control specimens. The reference range was unchanged
during the period.
In order to test for any shift in the analyses over time in
the present material, we estimated the Pearson correlation
coefficient between time of testing and CRP concentration
in a subsample of 681 patients. The correlation coefficient
was non-significant at 0.060 (p = 0.12). When sub group-
ing the material according to time of change of analyzers
and type of reagent kits, no statistically significant differ-Immunity & Ageing 2008, 5:8 http://www.immunityageing.com/content/5/1/8
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ences were found neither in mean ranks (p = 0.065) nor
in medians (p = 0.398).
Statistical methods
Since CRP-data and age were not normally distributed,
data are presented as medians and interquartile ranges
(IQR), and Mann-Whitney U tests were used to compare
the ranks of age in the bacteraemic patient group versus
the control group, and to compare the ranks of CRP1,
CRP2 and CRP3 in the three different bacteraemic patient
age groups. The Spearman rank correlation was used to
examine a possible linear association between age and
CRP1. The medians and IQRs of CRP1, CRP2 and CRP3
were depicted graphically. Contingency tables were used
to calculate the sensitivities of CRP1 according to age
group, bacteria, gender, and cut-off value (40, 80 and 120
mg/l, respectively). The confidence intervals of the sensi-
tivities were manually calculated, and Chi-squared tests
were used to compare the observed proportions. A 10%
difference in sensitivity was considered as clinically rele-
vant. A power analysis indicated that 294 patients in each
age group would be required to detect such a difference
with a power of 80% and a 5% significance level. Receiver
operating characteristics (ROC) curves for the three age
groups were constructed, and area under the curves (AUC)
was calculated. Z-tests were used to assess whether the
AUCs were statistically significantly different.
All tests were computed using SPSS -15.0 (SPSS Inc. Chi-
cago, IL, USA), or by hand. P-values less than 0.05 were
regarded as a sign of statistical significance. No attempts
were done to adjust for multiple comparisons.
Ethical considerations
The study was approved by the Regional Committee for
Ethics in Medical Research and by the Norwegian Data
Inspectorate, which gave permission to carry out the study
without the patients' consent.
Results
1150 patients had a positive blood culture with either E.
coli or S. pneumoniae during the study period. Of these,
260 had no registered CRP measurement on the same day
as the blood culture, reducing the number of eligible
patients to 890. Of these, 604 (68%) had had their blood
culture and CRP drawn on the day of hospital admittance.
634 (71%) of the patients had E. coli whereas the remain-
ing 256 had S. pneumoniae. Median age of bacteraemic
patients was 75 years (IQR 58–82). 300 (34%) patients
were < 65 years, 443 (49%) were 65–84 years, and 147
(17%) were ≥ 85 years. The percentages of E. coli in the
three age groups were 61%, 77% and 76%, respectively (p
=< 0.01), and the percentages of females were 58%, 50%
and 71% (p =< 0.01), respectively. 421 control patients
were eligible. Their median age was 77 years (IQR 62–83),
which was significantly higher than in the bacteraemic
group (p = 0.005). 120 (28%) of the controls were < 65
years, 223 (52%) were 65–84 years, and 84 (20%) were ≥
85 years.
The median concentration of CRP on the same day as the
positive blood culture (CRP1) was 188 mg/L (IQR 97–
288 mg/L). For the control group taken together the
median CRP concentration at admittance was 6 mg/L
(IQR 2–19 mg/L, range 1–303 mg/L), 5 mg/L (IQR 2–12
mg/L) for those with cerebral infarction and 7 mg/L (IQR
2–24 mg/L) for those with myocardial infarction. The
relation between CRP1 and age with trendlines is shown
in figure 1. The Spearman correlation coefficient was –
0.072 (p = 0.032) and 0.146 (p = 0.003) among the cases
and the controls, respectively. For bacteraemic patients
the median CRP1 was 209.5 (IQR 110–320), 175 (IQR
83–271) and 176 mg/L (IQR 103–278), in the youngest,
median and oldest age group, respectively. Corresponding
results among the controls were 4 (IQR 2 – 11), 6 (IQR 2
– 20) and 11 mg/L (IQR 3 – 43).
For bacteraemic patients, the medians and IQRs of CRP1,
CRP2 and CRP3 in the three age groups are shown in Fig-
ure 2. The youngest group had a significantly higher CRP1
level than the intermediate group (p = 0.003). For CRP2
both the difference between the youngest and the inter-
mediate group (p = 0.04) and the difference between the
youngest and the oldest group (p = 0.026), were statisti-
cally significant. There were no significant differences for
CRP3.
The sensitivity of CRP in detection of bacteraemia accord-
ing to age group, bacterial species and gender at different
cut-off values is shown in table 1. At all cut-off points, the
sensitivity is significantly better for S. pneumoniae than for
E. coli, but we were not able to identify any differences in
diagnostic sensitivity regarding age groups.
The ROC-curves for the different age groups are shown in
figure 3. The AUCs are 0.968 (95% confidence interval
(CI) 0.952–0.985), 0.940 (95% CI 0.922–0.958) and
0.923 (95% CI 0.888–0.958) for the age groups 16–64
years, 65–84 years, and ≥ 85 years, respectively. The AUC
for the youngest age group was significantly greater than
that for the intermediate as well as the oldest age group (z-
test, p < 0.05 for both comparisons).
Discussion
We were not able to confirm the hypothesis that the CRP-
response in bacteraemia is age-dependent to any clinically
important degree. There was a slight, though statistically
significant negative correlation between age and initial
CRP value as well as a higher area under the ROC curve for
the youngest patients, but this did not translate into a clin-Immunity & Ageing 2008, 5:8 http://www.immunityageing.com/content/5/1/8
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ically meaningful difference in sensitivity for any relevant
cut-off value for CRP. The study may have been under-
powered for a comparison of sensitivity, but when the age
groups were collapsed into broader classes (results not
shown), thus improving the power, the negative results
regarding sensitivity persisted.
Accordingly, this study supports the use of CRP as an indi-
cator of possible infection in the elderly with the same
cut-off values as in younger adults. This result should,
however, be interpreted with several reservations.
First, we cannot completely rule out selection bias, since
we do not know if the blood cultures in some instances
were drawn after the results of the CRP-tests were known,
thus increasing the possibility that some cases of bacterae-
mia remained undiagnosed in cases with low CRP. More-
over, fever is a very common indication for having a blood
culture drawn, but is less frequent in elderly patients with
infection [18]. Both factors could bias the results towards
higher CRP levels in the elderly patients, and this trend
may be strengthened by the fact that elderly patients more
often have non-infectious comorbid conditions character-
ized by high CRP concentrations.
Second, we lack information on the duration of symp-
toms prior to CRP testing. A substantial proportion of the
patients had their CRP1 drawn at admission. If there exists
a systematically increased pre-hospital delay among the
oldest, a slower CRP response in this group could be
masked.
Third, we have insufficient clinical information as to
include the potential confounding factors of comorbidity,
disability or frailty upon the CRP response, an association
that has been suggested by others [19,20]. Neither do we
have sufficient information on the clinical severity of the
infection.
It should be noted that our results are valid only for
bacteraemia with E. coli or S. pneumoniae. Our study was
not designed to assess the sensitivity of the CRP-response
for severe bacterial infections that does not result in a pos-
itive blood culture for one of these bacteria. Thus, one
Scatter plot of the relation between age and CRP concentration on the day of a blood culture positive for S. pneumoniae or E.  coli (cases), and for the controls Figure 1
Scatter plot of the relation between age and CRP concentration on the day of a blood culture positive for S. pneumoniae or E. 
coli (cases), and for the controls.
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should be careful in generalising our results to different
clinical settings. Furthermore, the choice of control group
can be criticized as both cerebral and coronary infarction
may lead to elevated CRP. However, the choice was based
on clinical grounds as these two conditions represent the
main alternative diagnoses in the emergency room, espe-
cially when dealing with elderly patients.
The small relative difference between the age strata per-
sisted at day 2–3, but disappeared at day 4–7 (Figure 2).
This weighs against the hypothesis that the CRP response
among the oldest is delayed, as in this instance we would
have expected the progress from the first to the second
assessment to differ according to age. It also weighs
against the hypothesis of a prolonged inflammatory
response in human old age [11], as is seen in aged mice
[21]. There may, however, have been a selection bias in
the ordering of a second and a third measurement. We
have no information on the reasons why these repeated
measurements were ordered.
Thus, taking these important reservations into account,
there is still a real possibility that there may exist a clini-
cally relevant age related difference in CRP response in
systemic infection, at least in invasive bacterial infections
Median CRP1 (on the day of the positive blood culture), CRP2 (2–3 days later), and CRP3 (4–7 days later) in different age  groups Figure 2
Median CRP1 (on the day of the positive blood culture), CRP2 (2–3 days later), and CRP3 (4–7 days later) in different age 
groups. The vertical bars indicate the interquartile range.
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Table 1: Sensitivity of a "high" concentration of C-reactive protein (CRP) as indicator of bacteraemia by gender, species, and age
Sex Species Age group
Female Male S. pneumoniae E. coli 16–64 65–84 ≥ 85
Cut-off (CRP) 40 mg/L Sensitivity (%) 90.2 88.2 92.6 88.0 90.4 88.5 90.5
95% CI 87.6 – 92.8 85.0 – 91.4 89.4 – 95.8 85.5 – 90.5 86.6 – 93.4 85.5 – 91.5 85.8 – 95.2
p-value 0.339 0.046 0.714
Cut-off (CRP) 80 mg/L Sensitivity (%) 81.4 75.6 89.1 74.8 82.0 75.6 82.3
95% CI 78.0 – 84.8 71.3 – 79.9 84.8 – 93.4 71.4 – 78.2 77.7 – 86.3 71.6 – 79.6 76.1 – 88.5
p-value 0.037 < 0.01 0.060
Cut-off (CRP) 120 mg/L Sensitivity (%) 69.7 64.6 82.4 61.5 71.7 64.8 67.3
95% CI 65.7 – 73.7 59.9 – 69.3 77.7 – 87.1 57.7 – 65.3 66.7 – 76.8 60.4 – 69.2 59.7 – 74.9
p-value 0.106 < 0.01 0.145
CI = confidence interval, p-values for between-group comparison of sensitivity (chi-square test)Immunity & Ageing 2008, 5:8 http://www.immunityageing.com/content/5/1/8
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not causing a positive blood culture. What factors are in
favour of this hypothesis?
In ageing research it is widely accepted that ageing is char-
acterized by a systemic, low-grade inflammatory state
[22]. It is also acknowledged that this subclinical proin-
flammatory status, interacting with genetic background
(evolutionary selection of proinflammatory genes benefi-
cial in early age), may trigger the onset of frailty and age-
associated diseases [22-24]. Innate immunity is viewed as
being mainly well preserved, but immune changes seen in
old age also affect innate immunity [24]. Studies on pos-
sible age-related changes in proinflammatory cytokines
(and thus the CRP response) in endotoxiemia have
yielded diverging results [25-28]. A recent study on gene
expression in endotoxin-stimulated macrophages from
young and old mice showed reduced expression of proin-
flammatory cytokines as well as Toll like receptor signal-
ling pathways with increasing age [29]. Another study
showed that the gene expression of proinflammatory
cytokines was significantly lower in aged mice than in
young at 24 hours after stimulation with endotoxin, but
higher at 72 hours [21]. Thus, although still controversial,
experimental studies do open up for a weaker proinflam-
matory response and thus a limited production of CRP.
There seems to be a convincing and clinically important
difference in the sensitivity of CRP between patients
infected with E. coli and  S. pneumoniae. This finding
accords well with the results of other studies. The CRP
concentration is associated with mortality and organ fail-
ure [30], and it is well known that S. pneumonia consist-
ently causes serious infections, while the range of severity
is much broader for infections with E. coli. The finding of
Receiver operating characteristics (ROC) curves for the relationship between initial CRP value and bacteraemia in different age  groups Figure 3
Receiver operating characteristics (ROC) curves for the relationship between initial CRP value and bacterae-
mia in different age groups. The sensitivity and the corresponding 1-specificity for the cut-points 40, 80 and 120 mg/L are 
indicated by circles, squares and diamonds, respectively.Immunity & Ageing 2008, 5:8 http://www.immunityageing.com/content/5/1/8
Page 7 of 8
(page number not for citation purposes)
a gender difference in sensitivity in one particular age stra-
tum, on the other hand, seems not biologically plausible,
and we suspect this association to be spurious.
Conclusion
We conclude that there exists a statistically significant
association between age and CRP in invasive bacterial
infections. However, this association may not be of a mag-
nitude that makes it clinically important for CRP as a diag-
nostic tool in bacterial infections associated with a
positive blood culture. Further studies are needed to
decide whether markers of the aging process such as
comorbidity and frailty influence the diagnostic value of
CRP as a marker of infection, as well as whether the diag-
nostic performance of CRP is affected by severity of infec-
tion.
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